APTARGROUP INC (ATR)
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ATR
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ATR | Independent Director | 56 | ["over 30 years of global financial and operational experience", "Chief Financial Officer and Principal Accounting Officer of Criteo S.A.", "Acting Chief Financial Officer at XPO, Inc.", "Senior Vice President, Corporate Finance and Transformation at XPO", "global executive roles at Novartis, Honeywell International and Bristol-Myers Squibb", "started career at PricewaterhouseCoopers", "served on the Board of Directors and was Chair of the Audit Committee for 2seventy bio, Inc.", "expertise in public company finance, accounting, strategic planning and risk management", "audit committee financial expert"] | ["Audit"] | 2026 |
Biography sourced from the proxy statement filing.
Ms. Glickman has over 30 years of global financial and operational experience, including in the pharmaceutical industry, and is currently the Chief Financial Officer and Principal Accounting Officer of Criteo S.A., a global commerce media company, since September 2020. She previously held the position of Acting Chief Financial Officer at XPO, Inc., a leading global provider of transportation and logistics solutions, where she previously served as Senior Vice President, Corporate Finance and Transformation. She also held global executive roles at Novartis, Honeywell International and Bristol-Myers Squibb and started her career at PricewaterhouseCoopers. From 2021 to 2025, Ms. Glickman served on the Board of Directors and was Chair of the Audit Committee for 2seventy bio, Inc., a biotech company (previously part of bluebird bio, Inc.). Ms. Glickman joined Aptar s Board of Directors in 2023. The Board of Directors concluded that Ms. Glickman should continue to serve as a director of Aptar due to her expertise in public company finance, accounting, strategic planning and risk management, having served in senior executive and financial oversight roles in various public companies. This experience has also led the Board to determine that Ms. Glickman is an audit committee financial expert as defined by the SEC.